Towards an MMP-2-activated molecular agent for cancer imaging

File Description SizeFormat 
MMP-Final-AuthorsCopy.pdfAccepted version868.68 kBAdobe PDFView/Open
MMP-SupplementaryInformation-Final-AuthorsCopy.pdfAccepted version1.32 MBAdobe PDFView/Open
Title: Towards an MMP-2-activated molecular agent for cancer imaging
Authors: Cowell, S
Carroll, L
Lavdas, I
Aboagye, E
Vilar Compte, R
Item Type: Journal Article
Abstract: Matrix metalloproteinases (MMPs) have been identified as biomarkers for cancer, offering prognostic potential; however, non-invasive detection protocols are currently lacking. Herein, we describe the synthesis of a DOTA-containing peptide sequence that can be radiolabelled easily with 68Gallium or can be incorporated with gadolinium for possible MRI applications with clear selectivity for MMP-2 over other members of the MMP family, giving MMP-2 selective cleavage of the labelled peptides.
Issue Date: 4-Dec-2017
Date of Acceptance: 4-Dec-2017
ISSN: 1477-9234
Publisher: Royal Society of Chemistry
Start Page: 1530
End Page: 1534
Journal / Book Title: Dalton Transactions
Volume: 47
Copyright Statement: © The Royal Society of Chemistry 2017
Sponsor/Funder: Cancer Research UK
Engineering & Physical Science Research Council (EPSRC)
Funder's Grant Number: 10337
Keywords: 0302 Inorganic Chemistry
0399 Other Chemical Sciences
Inorganic & Nuclear Chemistry
Publication Status: Published
Appears in Collections:Division of Surgery
Biological and Biophysical Chemistry
Division of Cancer
Faculty of Medicine
Faculty of Natural Sciences

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx